Real-time enrollment status for this ulcerative colitis clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 1:38 AM UTC
| NCT Number | NCT05076175 |
| Recruiting Status | Recruiting |
| Condition | Ulcerative Colitis |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | July 23, 2026 (Jul 23, 2026) |
As of August 29, 2026: Clinical trial NCT05076175 is currently recruiting participants. This phase2 study for ulcerative colitis is actively seeking new participants at 36 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05076175 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05076175 was last updated Jul 23, 2026 (July 23, 2026). HelloStudys verifies this status automatically.